Search
for
Sort by
Research 30 of 1000+
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Abstract 4350: Pharmacodynamic biomarkers: Evaluation of oncology drug target engagement in human plucked scalp and beard hair
- Therapeutic indications and other use-case-driven updates in the drug ontology: anti-malarials, anti-hypertensives, opioid analgesics, and a large term request
- Computational Drug Discovery in Chemotherapy-induced Alopecia via Text Mining and Biomedical Databases
- Dimensions of drug information
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Alopecia in oncology: the practical significance of fundamental research
- Injectable Macroporous Cryogels for Minimally Invasive Drug Delivery and Tissue Engineering
- Repurposed Drugs: Current Trends in Drug Discovery
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- Referee report. For: Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania [version 1; peer review: 1 approved, 1 approved with reservations]
- Drug repositioning: current approaches and their implications in the precision medicine era
- Drug Repurposing: Expanding Therapeutic Potential of Existing Drugs
- Drug-Loaded Extracellular Vesicle-Based Drug Delivery: Advances, Loading Strategies, Therapeutic Applications, and Clinical Challenges
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Roles of the Hedgehog Signaling Pathway in Cutaneous Physiology and Oncology
- Prostaglandins and Skin Cancer: An Old Pathway With New Insights in Cutaneous Oncology
- Antibody Drug Conjugates
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- An industry update: what’s new in the field of therapeutic delivery this month?
- Optimizing therapeutic delivery of microneedles through gas-propelled technology
- MendelVar: gene prioritization at GWAS loci using phenotypic enrichment of Mendelian disease genes
- Incidence of skin diseases diagnosed in a public institution: comparison between 2003 and 2014
- Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- DERMATOLOGICAL ADVERSE EFFECTS OF CHEMOTHERAPEUTIC AGENTS: EXPERIENCE FROM A TERTIARY CENTRE
- The dermatology consultant: A retrospective analysis of inpatient dermatology
- First National Chemotherapy Safety Standards Issued Jointly by ASCO & ONS
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras